Enter assignee name

EPO Patents = 5

Trademarks = 11

Forward Citations = 12

Loading Chart...

5 inventors (with patents filed for the assignee):

Bart Henderson (12 out of 17 patents)

Leonardus H T Van Der Ploeg (9 out of 32 patents)

Shubh D Sharma (5 out of 62 patents)

4. Louis Anthony Tartaglia (5 out of 33 patents)

5. Peter Kuhnen (1 out of 1 patent)

6. Leonardus HT Van Der Ploeg (1 out of 1 patent)

12 patents: Sort by Forward Citations

1. 12655178 - METHOD OF TREATING MELANOCORTIN-4 RECEPTOR-ASSOCIATED DISORDERS IN HETEROZYGOUS CARRIERS (2026-06-16),

2. 12285460 - Pharmaceutical compositions (2025-04-29),

3. 12263202 - Method of treating melanocortin-4 receptor pathway-associated disorders (2025-04-01),

4. 12077612 - Peptide compositions (2024-09-03),

5. 11702448 - Method of treating melanocortin-4 receptor-associated disorders in heterozygous carriers (2023-07-18),

6. 11129869 - Pharmaceutical compositions (2021-09-28),

7. 10960046 - Method of treating melanocortin-4 receptor pathway-associated disorders (2021-03-30),

8. 10954268 - Method of treating melanocortin-4 receptor-associated disorders in heterozygous carriers (2021-03-23),

9. 10858399 - Peptide compositions (2020-12-08),

10. 10196425 - Peptide compositions (2019-02-05),

11. 10167312 - Method of treating melanocortin-4 receptor-associated disorders in heterozygous carriers (2019-01-01),

12. 9845339 - Method of treating melanocortin-4 receptor-associated disorders in heterozygous carriers (2017-12-19),

Rhythm Pharmaceuticals, Inc. is a biopharmaceutical company dedicated to developing and commercializing peptide therapies for rare genetic disorders that result in life-threatening metabolic issues. The company's focus is on rare genetic disorders of obesity and leptin deficiency. Rhythm's innovative approach aims to provide targeted treatments for these conditions to improve patient outcomes and quality of life.

This text is generated by artificial intelligence and may not be accurate.